Colchicine Synergism of Mouse Hair Root Changes Produced by X-ray Irradiation11From the Department of Medicine (Section of Dermatology), Department of Radiology and Argonne Cancer Research Hospital, University of Chicago, Chicago 37, Illinois.This work was supported in part by Public Health Service Grant No. E-1444(C5).Presented at the twenty-second Annual Meeting of The Society for Investigative Dermatology, Inc., New York, N.Y., June 27, 1961.  by Malkinson, Frederick D. et al.
COLCHICINE SYNERGISM OF MOUSE HAIR ROOT CHANGES PRODUCED BY
X-RAY IRRADIATION *
FREDERICK D. MALKINSON, M.D., MELVIN L. CRIEM, M.D. AND
PETER R. MORSE, A.B.
The occurrence of anagen alopecia in rats and
mice following the intraperitoneal administra-
tion of coichicine was reported two years ago
(1). It was observed then that the atrophic and
dystrophic changes induced by this drug in the
matrix and shaft of anagen hairs bore a striking
resemblance to the morphologic alterations oc-
curring in growing hairs following x-ray irradia-
tion (2). In view of the gross similarity in the
forms of damage produced by these two modalities
and the known effects of certain chemical and
physical agents in modifying radiation responses
in tissues (3—6), it was decided to explore the
possible synergistic action of colehicine in in-
creasing x-ray effects. Our chief interest centered
on the possible therapeutic implications of alter-
ing the radiation responses of certain forms of
malignancy by prior administration of colehicine.
Some earler aspects of this work have been pub-
lished elsewhere (7).
METHOD
All studies were carried out on adult female
mice of the Carworth Farms No. 1 strain. Since
hairs in telogen, or the resting phase of the hair
cycle, are mitotically inactive and hence insensi-
tive to radiation (5), the hairs were plucked at
the experimental sites in order to induce anagen,
the radiosensitive stage of active growth. In the
strain of mice used there is a span of seventeen to
twenty days between earliest anagen and the onset
of telogen. At the start of each experiment hairs
were completely plucked from both haunches of
all animals, one haunch being used for examination
of the combined effects of colchicine and irradi-
ation, and the other for examination of colehicinc
effects alone.
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The mice received x-ray irradiation on the
tenth day after the initial plucking, and four days
later the newly growing anagen hairs were plucked
from both the control and the treatment sites.
These hairs were then placed in water just suffi-
cient to cover the bottom of a 5.5 x 1.5 em. glass
petri dish which had been scored in grid fashion
on the undersurface to facilitate hair counting.
The hairs were examined with a binocular dis-
secting microscope at 45X magnification using
transmitted blue light which provided better
visualization of hairs than the usual light source.
For each animal 100 hairs were counted from both
the control and irradiated sites and the following
stages of hair growth were recorded and counted
for the "differential hair count:" normal anagen,
dysplastie (Fig. 1), catagen (hairs transitional
between anagcn and telogen), and telogen.
Two similarly trained individuals performed
all the hair counts and their results in initial
trials were consistently in close agreement,
although it is possible that the criteria for scoring
minimal dysplastic changes varied slightly from
one observer to the other. Nonetheless it has been
our experience that this variation appears to be
constant for each individual. For this reason the
same person performed all counts in a given experi-
ment. During each series of counts a variable
rotational sequence of control and treated animals
was used to minimize observer bias, fatigue, and
criteria variation. Every cage of animals con-
tained one mouse from each experimental group
and each cage was analyzed completely before
examining the next group of animals. This pro-
cedure eliminated all "cage" effects as shown by
statistical analysis of our data.
Before initiating studies on the combined
effects of colchicine and x-ray irradiation, the
dysplastie changes in hair produced by irradiation
alone at different dosage levels were studied. In
these experiments radiation was administered
with a Maehlctt OEC-60 tube operated at 50 kv
and 30 ma with 2 mm. of aluminum added filtra-
tion. This produced a dose rate of 387 r per min-
ute surface dose at a focal skin distance of 11 em.,
and a beam quality of 1.2 cm. half value depth in
tissue. The animals were adequately shielded and
treated individually without anesthesia. Surface
dosages were begun at 200 r and increased by 100 r
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at a dosage of 1 mg/kg (in the Carworth Farms
No. 1 mouse 5 mg/kg was found to be the LDa
for this drug). Since coichicine alone is known to
produce dysplastic changes in hair, dosages
ranging from 1.0—5.0 mg/kg were given to groups
of five mice ten days after plucking and 100 hairs
were counted from each animal (Fig. 2). When
0.5—1 mg/kg of colchicine was given intraperi-
toneally less than two dysplastic hairs per 100
hairs were found in almost all animals examined,
and in over one-half of these animals no dysplastic
hairs were present. Because of the insignificant
effects produced in hair by colchicine alone at
the dosage level of 1 mg/kg this dosage was used
throughout the study.
In the animals receiving combined treatment a
constant dosage of radiation (400 r) was adminis-
tered to different groups of animals at successive
time intervals after the injection of eolchicine.
Each group of ten mice received radiation only
once. The percentage of damaged hairs was
plotted graphically as a function of the time
interval between the administration of colchicine
and irradiation.
Mercaptoethylamine (MEA) was given intra-
peritoneally in physiological saline in a dosage of
1 mg per 10 g of body weight. It was regularly
administered fifteen minutes prior to x-ray
irradiation.
All experimental data was statistically analyzed
using an analysis of variants.
RESULTS
FIG. 1. X-ray induced changes in mouse hairs
showing narrowed hair shaft and matrix atrophy.
increments to 900 r. For each change in radiation
dosage a different group of five animals was used,
and for each animal 100 hairs were counted from
both the treated and the unirradiated flank
(Table 1). The incidence of dysplastic hairs ranged
from about six per cent for a surface dose of 200 r
to about 86 per cent for a surface dose of 900 r.
When a dose of 400 r was used we consistently
found between 46 and 52 per cent dysplastic
hairs among the 500 hairs counted. This same
radiation dosage was then used in the animals
treated with colchicine so that both protective
and synergistic effects on the radiation reaction
could be studied.
Colchicine* was administered intraperitoneally
* Colchicine was kindly supplied by Dr. G. W.
Irwin of the Lilly Research Laboratories. The drug
The results of two separate experiments are
shown in Figs. 3 and 4. Both of these graphs
demonstrate a significant synergistic effect when
there is a 16-hour interval separating colchicine
administration from x-ray irradiation. Both
graphs also show a decreased response at the end
of 24 hours after the earlier sixteen-hour peak. No
protective effect of colehieine was observed in
these studies. The results have been found to be
consistent in two additional series of animals
treated identically, but for which graphs are not
here reproduced.
Because of a second suggestive peak of syn-
ergistic action seen following early treatment,
four further series of animals were irradiated at
frequent time intervals up to 3 hours after the
administration of colchicine. A graph from one of
these studies (Fig. 5) reveals that no statistically
significant peak could be identified.
An investigation is currently in progress on the
was used as provided, each ampule containing 1
mg of colchicine in 2 cc. of aqueous solution.
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TABLE I
Incidence of dys plastic hairs observed 7 hours after irradiation at graduated dosage levels
SURFACE DOSE
IN ROENTGENS
PERCENT
DYS PLASTIC
HAIR
STANDARD
DEVIATION
200 §.6 2.8
300 7.6 4.2
400 46.8 1.6
500 59.8 7.9
600 71 3.5
700 78 5.7
800 82.4 6.7
900 87.8 5.9
I-(I)
-J
0
2.0 3.0
COLCHICINE mg/kg
Fro. 2. Incidence of dysplastic hairs observed 72 hours after intraperitoneal injection of increasing
dosages of colchicine. Coichicine 1 mgm/kg was injected in all experiments where the combined effects
with irradiation were studied.
effects of reversal of the colchicine—x-ray se-
quence of treatment.
In the series of animals treated with the radio-
protective compound MEA no inhibition of x-ray
or colchicine effects alone, or of the sixteen-hour
synergistic peak, could be demonstrated (Table
2). These studies are being repeated with higher
dosages of MEA, with 2-aminoethylisothiourea
(AET), and with small non-irritating quantities
of both compounds injected locally.
U
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1
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0
HOURS
FIG. 4. Second experiment showing the effect of varying time intervals between injection of coichicine
and administration of x-ray on the production of dysplastic hairs. The 16-hour peak is again seen.
CLINICAL
When our initial laboratory studies indicated
that there was a synergistic effect of combined
treatment with coichicine and x-ray irradiation,
we attempted to evaluate the possible thera-
peutic effects of these two agents in a patient with
the infiltrative and tumor stages of mycosis
fungoides. Surprisingly, this patient was unre-
sponsive to surface doses of 600 r in a single
exposure given at 150 kv and 50 cm focal skin
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FiG. 3. Note the peak incidence of dysplastic hairs when irradiation is given 16 hours after coichicine.
Suggestive peak at 2 hours was not statistically confirmed in later studies. (See Fig. 5.)
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Fin. 5. One of 4 experiments which failed to show a statistically significant synergistic effect of coichi-
cine when irradiation was given at frequent intervals during the first three hours after administration
of the drng.
distance with 3 mm aluminum added filtration.
After intravenous administration of 3 mg of
colchicine a single surface dose of 600 r was
given through successive 10 x 10 cm portals along
the leg and lower back every 4 hours for 16 hours.
Final treatment evaluation two weeks later re-
vealed no detectable change in the 4-hour and
8-hour portals. The 12-hour portal showed a
distinct decrease in erythema and infiltration
with sharp demarcation of the portal borders.
The 16-hour treatment site showed similar but
even more striking improvement with almost
total flattening of most of the infiltrates. Com-
bined treatment usiag the 16-hour interval be-
tween colchicine administration and irradiation
was repeated a number of times for other involved
sites and a good response was noted on each
occasion.
Following these observations in one patient we
have selected a number of patients with usually
unresponsive tumors for clinical trial. These
individuals have received colchicine 4 mg. intra-
venously followed by tumor irradiation in doses
of 400 to 500 rads sixteen hours later twice
weekly for periods up to four weeks. All treat-
ments have been carried out carefully in hospital-
ized patients only, and to date no serious difficulty
has been encountered from therapy. Occasionally
there has been a transitory leukopenia with a
Results of administration of neroaptoethylsmine (IRA).
dysplastic hairs
Standard deviation of the mean 5.738
marked shift to immature forms of the granulo-
cytic series, and rarely diarrhea has necessitated
discontinuation of colchicine. Although a number
of patients are currently receiving therapy it is
too early to evaluate the treatment results.
DIscussIoN
The concept that prior administration of
colchicine might enhance tissue responses to x-ray
irradiation was first advanced over twenty years
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TABLE II
Experimental data showing lack of protection of
MEA against the induction of dys plastic hair
changes by irradiation alone or in combination
with cotchicine
TABLE II
400 r only 47.2%
Colohicine 1 mgnVkg. H 6.8%
Colchicine 1 mgWkg. H and 400 r X—ray
16 hours later 69.2%
Colchicine 1 a5is/kg. H; MEA 1 m/l0 gm. IP
and 400 r x—ray 16 hours later 60.0%
IRA 1 mm/l0 p's. H and 400 r X-ray 50.0%
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ago (9—13). At that time, however, the possible
beneficial effects of combined treatment were
proposed on the basis of earlier theories that
ionizing radiation exerted the most harmful
effects on mitotic chromosomes. More recent
work indicates that the most radiosensitive
stage of the cellular cycle is early prophase, or
certain stages of interphase, while cells in meta-
phase, the stage of mitotic arrest induced by
colchicine, are relatively radioresistant (14, 15).
Furthermore, little attention was devoted to the
significant feature of time-dosage relationships in
the early studies on colchicine—x-ray effects.
Although some rather elaborate technics have
been used in the past to investigate tissue changes
following combined colchicine and x-ray therapy,
the results have been equivocal. Previous investi-
gators have been faced with the problems of
excessive tissue handling and the lack of a suita-
ble biological indicator system which would lend
itself to simple and objective measurement of the
synergistic effects of colchicinc and irradiation in
contrast to the use of either agent alone. This
problem appears to have been solved satis-
factorily by the technic of microscopic exami-
nation of newly plucked hairs described above.
In fact, further applications of this useful tech-
nic to the investigation of other problems
concerning the effects of cytotoxic agents or
irradiation arc apparent.
The experimental findings reported here indi-
cate that eolchicinc produces a synergistic effect
on atrophic and dysplastic changes iii the hair
matrix and hair shaft induced by x-ray irradia-
tion, and that these alterations arc observed
only when the administration of colchicinc pre-
cedes irradiation by sixteen hours. No other time
interval studied showed significant colchicine
effects. Failure to reverse the colchiciac and
x-ray changes with the radioprotcctivc com-
pound MEA may be the result either of inade-
quate dosage or of disparate protective efficacy
in different tissues, an effect which has been
described previously for such compounds.
The mechanism of the synergistic action of
colchicinc on irradiation is as yet unexplained.
It seems likely that enhanced hair damage
results from the combined effects of two (related
or unrelated) forms of cellular injury separately
induced by the drug and by irradiation, and
which arc independent of colchicinc's anti-
mitotic properties. ft is hoped that further studies
with radioprotective compounds such as MEA
and AET, or perhaps with colchicine thhibitors
such as tropolonc (16), will provide some informa-
tion on this subject.
The effects of combined treatment with colchi-
cinc and x-ray irradiation on other normal or
abnormal tissues is not yet known. It has been
shown, however, in both tumor-bearing humans
and experimental animals that there is a dimin-
ished urinary excretion of drug following admin-
istration of C'4 labeled colchicinc (17). Under
these conditions it is possible that the absorp-
tion, retention, and metabolism of colchicine are
different in humans and animals with tumors.
The cytologic effects of the drug or its metab-
olites, and those properties responsible for x-ray
synergism, could conceivably be enhanced by
these differences
sUMMARY
1. The technic for microscopic examination of
plucked hairs has been used in mice to demon-
strate that colchicinc exerts a synergistic effect on
dysplastic changes induced in growing hairs by
x-ray irradiation.
2. Significant synergism has boon found only
when a specific time interval of 16 hours separates
colchicinc administration from x-ray irradiation.
No protective effect of colchicinc was observed
in these studies.
3. A clinical response to combined intravenous
colchicine and x-ray therapy has been described
for a single patient with mycosis fungoides. Such
therapy is currently undergoing further evalua-
tion in a group of patients with diverse and ad-
vanced malignancies.
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DISCUSSION
DR. MARiON B. SULZBERGEE: First of all, I
would like to say how pleased I am to hear this
paper, how highly I think of this work and its
possible importance.
Then, I would like to ask Dr. Malkinson and
his co-workers a couple of questions:
One is: why does he use the word, "synergis-
tic"? Has it actually been proven that this is
more than an additive effect?
The second question that I have deals with the
last sentence of the conclusions, or one of the
last sentences, and that is that the observed
effect has nothing to do with the antimitotic
activity of the colchicine.
Ten or eleven years ago, I had the idea to try
to use systemically administered colcbicine to en-
hance the effectiveness of irradiation therapy in
human diseases like warts and malignancies and
other rapidly growing cellular tumors just be-
cause it did arrest mitoses. My idea was based on
the hypothesis that if one could produce the
Dustin effect and arrest a large number of the
mitoscs in a certain phase, in the metaphase, this
might make the nuclei a better target and make
the arrested chromosomes more susceptible to the
x-ray than if one just let them go on multiplying
haphazardly.
I would like to know whether Dr. Malkinson
knows or can say anything about whether this
16-hour critical time interval he observed corre-
sponds with the time interval after colchicine
administration when one does see most of the
cells in the arrested mitoses—produccd by the
coichicine.
Dii. EUGENE J. V SCOTT (Bethesda, Mary-
land): One may suspect (and there are a number
of reasons why one may think so) that a tissue is
more susceptible to irradiation if that tissue is
high in mitotic activity. One wonders if following
colchicine administration there is first an arrest
of mitoses, or a decrease in mitotic activity, and
then a rebound to greater than normal actvity,
as happens following ultraviolet light.
Is there any evidence that in 16 hours increased
mitotic activity occurs in the hairs of the mice
given colchicine?
Secondly, since mice require over 1 milligram
per kilogram of colchicine to show dysplasia of
the hairs, would a total dose of three milligrams
per patient be expected to have any effect on
mitotic activity of the tissues of the human?
DR. WILLIAM L. EPSTEIN (San Francisco,
California): I would like to ask Dr. Malkinson a
question first. Has he used griscofulvin in his test
procedure? And, secondly, I would like to speak
to Dr. Van Scott's point.
We find using colcemidc, which is a less toxic
colchicine-like agent, that the number of "halted"
mitoscs in human skin increases with time. They
used to say the peak anti-mitotic effect was at 6
hours, but we see an accumulation of "colchicine
cells" for almost 24 hours. After this time the
cells escape and fewer mitoses arc seen. The
point is more "colchicine cells" are available
between 12 and 24 hours than earlier. If these
altered cells are shown to be especially radio-
sensitive it may explain Dr. Malkinson's observa-
tion that x-ray is most effective when given 14-48
hours after colchicine.
Dii. VAN SCoTT: The number of mitosis or
mitotic index following a drug such as colchicinc
does not indicate the mitotic activity. Since this
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drug arrests mitosis the numher of mitoses can-
not indicate activity of cellular reduplication.
DE. FEEDEEICK D. MALKINSON (in closing): I
want to thank the discussors.
In answer to Dr. Sulzherger's questions, we
call this a synergistic effect because throughout
these studies we used the dosage of 1 milligram
per kilogram of colehicine which almost never
produces more than 2 to 3 per cent dysplastie
hairs in the mouse.
Now, the 16-hour peak is a peak which is com-
posed of a base-line of 46 to 52 per cent dysplastic
hairs produced by irradiation, plus the small
added percentage which is the result of prior
administration of colchieine. Since this peak was
characterized by 65 to 70 per cent or more dys-
plastic hairs, it seemed to us that the term
"synergistic" was appropriate.
The relationship of mitotic arrest and radio-
sensitivity I unfortunately didn't have time to go
into, but there is now a good body of work in the
literature which shows that the most radiosensi-
tive phase of the cellular cycle occurs during very
early prophase or during certain stages of inter-
phase and that the cells in the later stages of
mitosis are actually relatively radioresistant. It is
for this reason we feel that there must be another
explanation for synergism rather than the anti-
mitotie effect of colehicine.
Dr. Van Scott asked whether it was possible
that there would be an increased mitotic activity
in the hair by the end of 16 hours. I cannot give
an answer to that, except to say that from the
in vivo and in vitro work that has been reported,
it seems quite unlikely to me that the cells
would have recovered sufficiently by the end of
16 hours to undergo an enhanced mitotie turn-
over rate.
The 3 milligrams total dose in humans was
chosen rather arbitrarily. We have since found
that 3 to 4 milligrams is the highest intravenous
dose that one can give a human without getting
rather severe untoward effects; and, in further
answer to the question, yes, this does produce
antimitotie effects in the tissues of man, as has
been shown by Brown and Seed (Am. J. Clin.
Path., 15: 189, 1945) many years ago.
In answer to Dr. Epstein, I think most of you
are probably quite familiar with the interesting
work that he has done with griseofulvin and
eolehicine. We have not yet had a chance to work
with griseofulvin. Griseofulvin is of considerable
interest in regard to our studies because it also
has antimitotic effects which are very similar to
eolchicine; that is, it arrests mitosis in the stage
of metaphase, although these are usually normal
rather than abnormal metaphase figures. The
"antispindle" effect is considerably less and the
antimitotie potency of the drug is also much less
than that of colehieine.
